Inhibition of HCV replication in HCV replicon by shRNAs

被引：3
|
作者：
Hamazaki, Hiroyuki
Takahashi, Hitoshi
Shimotohno, Kunitada
Miyano-Kurosaki, Naoko
Takaku, Hiroshi
机构：
[1] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan
[2] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 2750016, Japan
[3] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 606, Japan
来源：
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 2006年 / 25卷 / 07期
关键词：
RNAi; long dsRNA; shRNA; HCVIRES/core; HCV replicon; anti-HCV;
D O I：
10.1080/15257770600726091
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
We show that the vector-derived long dsRNA specifically inhibits the replication of HCV RNA in HCV replicon. We designed a long dsRNA targeted to the full-length HCV IRES/core elements (1-to 377-nt). Our results revealed that the replication of HCV RNA was reduced to near background levels in a sequence-specific manner by the long dsRNAs in the HCV replicon. We also designed four shRNAs against several regions (120- to 139-nt, 260- to 279-nt, 330- to 349-nt, and 340- to 359-nt) of the HCV IRES/Core elements. The two HCV IRES/core-specific shRNAs, 330- to 349-nt and 340- to 359-nt, containing the AUG initiation codon sequence showed stronger HCV inhibitory effects than the other two shRNAs, 120- to 139-nt and 260- to 279-nt.
引用
收藏
页码：801 / 805
页数：5
相关论文
共 50 条
  • [31] Inhibition of HCV Replication by Cyclophilin Antagonists Is Linked to Replication Fitness and Occurs by Inhibition of Membranous Web Formation
    Madan, Vanesa
    Paul, David
    Lohmann, Volker
    Bartenschlager, Ralf
    GASTROENTEROLOGY, 2014, 146 (05) : 1361 - +
  • [32] Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells
    Nishimura-Sakurai, Yuki
    Sakamoto, Naoya
    Mogushi, Kaoru
    Nagaie, Satoshi
    Nakagawa, Mina
    Itsui, Yasuhiro
    Tasaka-Fujita, Megumi
    Onuki-Karakama, Yuko
    Suda, Goki
    Mishima, Kako
    Yamamoto, Machi
    Ueyama, Mayumi
    Funaoka, Yusuke
    Watanabe, Takako
    Azuma, Seishin
    Sekine-Osajima, Yuko
    Kakinuma, Sei
    Tsuchiya, Kiichiro
    Enomoto, Nobuyuki
    Tanaka, Hiroshi
    Watanabe, Mamoru
    JOURNAL OF GASTROENTEROLOGY, 2010, 45 (05) : 523 - 536
  • [33] Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells
    Yuki Nishimura-Sakurai
    Naoya Sakamoto
    Kaoru Mogushi
    Satoshi Nagaie
    Mina Nakagawa
    Yasuhiro Itsui
    Megumi Tasaka-Fujita
    Yuko Onuki-Karakama
    Goki Suda
    Kako Mishima
    Machi Yamamoto
    Mayumi Ueyama
    Yusuke Funaoka
    Takako Watanabe
    Seishin Azuma
    Yuko Sekine-Osajima
    Sei Kakinuma
    Kiichiro Tsuchiya
    Nobuyuki Enomoto
    Hiroshi Tanaka
    Mamoru Watanabe
    Journal of Gastroenterology, 2010, 45 : 523 - 536
  • [34] PERTURBATION OF HCV REPLICATION BY MICRORNAS WHICH ARE REGULATED BY HCV INFECTION
    Ishida, Hisashi
    HEPATOLOGY, 2009, 50 (04) : 956A - 957A
  • [35] Bile Acids Promote HCV Replication through the EGFR/ERK Pathway in Replicon-Harboring Cells
    Patton, John B.
    George, David
    Chang, Kyeong-Ok
    INTERVIROLOGY, 2011, 54 (06) : 339 - 348
  • [36] siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations
    Konishi, Masayoshi
    Wu, Catherine H.
    Kaito, Masahiko
    Hayashi, Kazuhiko
    Watanabe, Shozo
    Adachi, Yukihiko
    Wu, George Y.
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (11) : 756 - 761
  • [37] Characterization of the Mechanism of Action of PG-301029: A Novel Late Stage Inhibitor of HCV Replicon Replication
    Parsley, Todd
    Yang, Lu
    Buckheit, Robert, Jr.
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A31 - A31
  • [38] RNA interference against the regulatory 3′-untranslated region efficiently inhibits HCV subgenomic replicon replication
    Korf, M.
    Meyer, A.
    Manns, M. P.
    Krueger, M.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S154 - S154
  • [39] Sequence requirements for the development of a chimeric HCV replicon system
    Gates, AT
    Sarisky, RT
    Gu, BH
    VIRUS RESEARCH, 2004, 100 (02) : 213 - 222
  • [40] Analysis of permissive cell lines for HCV replicon.
    Chen, CH
    Enomoto, N
    Maekawa, S
    Tanabe, Y
    Kanazawa, N
    Nakagawa, M
    Yamashiro, T
    Sakamoto, N
    Kurosaki, M
    Watanabe, M
    HEPATOLOGY, 2003, 38 (04) : 472A - 472A
12345